Stephen W. Kidder’s Pfizer PFE Stock Holding History

Stephen W. Kidder’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,403	Closed	-$220K	–	93
2017 Q4	$220K	Sell	6,403 -460	-7%	-$15.7K	0.08%	91
2017 Q3	$232K	Sell	6,863 -2,108	-23%	-$67.8K	0.09%	88
2017 Q2	$286K	Hold	8,971	–	–	0.11%	82
2017 Q1	$292K	Sell	8,971 -1,054	-11%	-$33.2K	0.11%	82
2016 Q4	$309K	Hold	10,025	–	–	0.13%	82
2016 Q3	$322K	Sell	10,025 -1,739	-15%	-$58.1K	0.13%	77
2016 Q2	$393K	Buy	11,764 +317	+3%	+$10.1K	0.16%	77
2016 Q1	$322K	Hold	11,447	–	–	0.13%	82
2015 Q4	$351K	Hold	11,447	–	–	0.15%	75
2015 Q3	$342K	Sell	11,447 -369	-3%	-$11.8K	0.17%	68
2015 Q2	$376K	Hold	11,816	–	–	0.17%	69
2015 Q1	$390K	Sell	11,816 -94	-0.8%	-$2.99K	0.17%	74
2014 Q4	$352K	Hold	11,910	–	–	0.15%	78
2014 Q3	$334K	Buy	+11,910	New	+$334K	0.15%	81

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Stephen W. Kidder's PFE Position: Q1 2018 in Review

Stephen W. Kidder sold out of Pfizer (PFE) in Q1 2018, closing a stake of 6,403 shares — an estimated $220K sold.

Stephen W. Kidder first reported a position in PFE in Q3 2014 and held it in 14 quarters. The position peaked at $393K in Q2 2016. 2,231 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

Stephen W. Kidder reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
Stephen W. Kidder sold 6,403 Pfizer shares in Q1 2018, an estimated $220K.
Stephen W. Kidder first reported a position in Pfizer in Q3 2014 and held it in 14 quarters.
Stephen W. Kidder's Pfizer position peaked at $393K in Q2 2016.
2,231 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Stephen W. Kidder's 13F filing for Q1 2018, filed 24 Apr 2018.